Company detailsCompany name: Ypsomed Holding AGGroup name: Ypsomed Holding AGCompany country: SwitzerlandNumber of employees: 1500Sector: C - ManufacturingSector detail: C26 - Manufacture of computer, electronic and optical productsSub-sectors: C26.5 - Manufacture of instruments and appliances for measuring, testing navigation; watches and clocks Reshoring detailsReshoring announcement date: 23/04/2018Reshored to: SwitzerlandLocation of affected unit(s): BurgdorfReshored business function: ProductionReshoring governance mode: In house (in own facilities)Reasons for reshoring: Automation of production processRationalization of costsCase narrative: Ypsomed is a Swiss-based developer and manufacturer of devices for self administration of insulin (e.g. pens). In 2018, the company decided to reshore to Switzerland the production of insulin pens it had been outsourced and offshored in Mexico in the '80. The reshoring decision was implemented after huge investments in technology; among them, the adoption of automated production process - within the company and its suppliers - and the digitalization of selected production processes through the 5G telecommunication technology (realized in partnership with Swisscom). These technologies allowed simpler, safer, and more efficient processes, increasing company's flexibility and reducing production costs. Sources: Ypsomed 05/03/2018 Swisscom 23/04/2018 20min.ch 09/09/2018 Sources link: https://www.ypsomed.com/de/medien-investoren/medienmitteilungen/medienmi... https://www.20min.ch/finance/news/story/Schweizer-Industrie-Firmen-holen... https://www.swisscom.ch/en/business/enterprise/themen/connectivity/5g-ap... Offshoring detailsOffshoring date: 1980Offshoring location: MexicoOffshored business function: ProductionOffshoring governance mode: Third party (external suppliers)Host country geographical area: North America